BioPharma Credit PLC (BPCP.L) LSE

Currency In GBp

AD

Valuation

Market Cap1.04B
Enterprise Value1.03B
P/E Ratio10.3
PEG Ratio-0.77
Price/Sales Ratio9.14
Price/Book Ratio0.97
Enterprise/Revenue8.57
Enterprise/EBITDA18.09

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.89
Operating Margin0.89
AD

Management Effectiveness

Return On Assets0.09
Return On Equity0.09

Income Statement

Revenue140.23M
Revenue/Share0.11
Gross Profit114.5M
EBITDA129.89M
Net Income129.89M
Diluted EPS0.11

Balance Sheet

Total Cash68.71M
Total Cash/Share0.06
Total Debt0
Total Debt/Equity0
Current Ratio26.43
Book Value Per Share1.01

Price History

52-Week Change6.67
52-Week High74.97
52-Week Low0.64
Moving Average 50 Days0.73
Moving Average 200 Days0.7

Statistics

Average Volume14,700
Shares Outstanding1.12B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.08
Trailing Annual Dividend Yield8.6
Payout Ratio1.04
Last Split FactorN/A
Last Split DateN/A
AD